RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @albtur_mnymkrs: @TedTheBigRedDog Hello, what information were you looking for? Maybe I can direct you. I don’t have anything clickable…

@mabbpah @metacollectiveG @MDendream @dcvaxdaw @JackNdreu Nobody cares about your opinion on $NWBO https://t.co/Y7qysnUE1z

RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…

RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…

RT @Silver_Suntan: @InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $…

@InvestorTurf Citadel (and others) are also being sued for engaging in manipulative spoofing of a small biotech called $NWBO who has a promising and JAMA published immunotherapy for brain cancer called DC-VAX. https://t.co/K6WF6e9J1o https://t.co/BtKx3B0

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @apwriter: $nwbo

RT @johnlane45: $NWBO #DCVax

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @rsloftx: $nwbo #nwbo $dcvax #dcvax #murcidencel

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @apwriter: $nwbo

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

https://t.co/GJR6YJayZ0 $nwbo @alphavestcap

NCI Neuro-Oncology Branch @NIHBrainTumor Today.. Liau of @UCLANsgy. '22, Dr. Liau published a phase 3 study in @JAMAOnc, investigating if dc vax L.. added ... to standard of care extends survival in glioblastoma patients: https://t.co/OGaOxGg45B $nwbo @al

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

$nwbo #nwbo $dcvax #dcvax #murcidencel

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @DocOck222: Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

$NWBO #DCVax

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

$nwbo

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

Dr. Linda Liau is an American Hero !!!! 🦸🏻‍♀️🇺🇸 👩🏻‍⚕️

$NWBO

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

RT @BIO99_BIO99: Welcome to the NCI, Dr. Liau. $NWBO

Welcome to the NCI, Dr. Liau. $NWBO

RT @EveryTrade: $NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

$NWBO Uh yea, she's kind a big deal. Thank You Dr. Linda Liau !!! https://t.co/nlGtzEpHpR

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

RT @NIHBrainTumor: Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investig…

Today’s Visiting Scholar is Linda Liau of @UCLANsgy. Last year, Dr. Liau published a phase 3 study in @JAMAOnc, investigating if adding autologous tumor lysate-loaded dendritic cell vaccine to standard of care extends survival in glioblastoma patients: htt

RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…

RT @sharpie510: @ourbrainbank Dr. Steven Brem is a co-author of the phase 3 #DCVax-L paper published in @JAMAOnc. Looking forward to an upd…